CBP-1018

Overview

CBP-1018 is a PDC (peptide-drug conjugate) formed by conjugating Monomethyl auristatin E ( HY-15162 ) to a dual-targeting ligand of FLOR1 / PSMA (prostate-specific membrane antigen) via a linker ( HY-78738 ). CBP-1018 binds to FLOR1 and prostate-specific membrane antigen ( PSMA ). CBP-1018 is applicable to the research of solid tumors and metastatic castration-resistant prostate cancer .

Application

Products | Products > Peptides | Products > Disease Areas > Prostate Cancer | Products > Disease Areas > Urogenital Cancer | Products > Disease Areas > Castration-Resistant Prostate Cancer | Products > Disease Areas > Cancer | Products > Disease Areas > Urogenital Disease | Products > Signaling Pathways > Antibody-Drug Conjugate/ADC Related | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Drug Resistance | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Peptide-Drug Conjugates (PDCs) | Products > Signaling Pathways > PSMA | Products > Signaling Pathways > Folate Receptor (FR)

Product Information

• Catalog No.: HY-P10740
• CAS No.: 2923068-30-6
• Molecular Formula: C132H192N30O38S
• Molecular Weight: 2839.18
• Purity: 99.21%
• Storage: Sealed storage, away from moisture. Powder -80°C, 2 years , -20°C, 1 year * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Availability: In-stock

Source

Original product source